Xion Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 2007.
2007 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Xion Pharmaceuticals Private Limited

Xion Pharmaceuticals Private Limited, a active private limited company, was established on 04 June 2007 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231PN2007PTC130248. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Formerly known as Jodhawat Enterprises Private Limited. It upholds a compliant status. Its leadership includes Mahendra Champalal Jain (Director), Rajeshkumar Champalal Jain (Director), Roshan Champalal Jain (Director). It holds ₹8.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No. 102 & 103, Park Plaza, First Floor, Opp Kamala Nehru Park, Erandwane,, Pune, Maharashtra, 411004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231PN2007PTC130248

  • Registration Number

    130248

  • Incorporation Date

    04 June 2007

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 18 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.00 M
  • Revenue Growth **** 57598.60%
  • Profit Growth **** 6049.73%
  • Ebitda **** -446152.29%
  • Net Worth 100325.77%
  • Total Assets **** 99961.56%
Company report

Xion Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Xion Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Xion Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahendra Champalal Jain Director 04 Jun 2007 Current
Rajeshkumar Champalal Jain Director 04 Jun 2007 Current
Roshan Champalal Jain Director 04 Jun 2007 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Xion Pharmaceuticals.

Xion Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 57598.6% increase. The company also saw a substantial improvement in profitability, with a 6049.73% increase in profit. The company's net worth Soared by an impressive increase of 100325.77%.

Xion Pharmaceuticals revenue growth over time
Xion Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 57598.60%
*******
*******
*******
*******
Revenue from Operations
*******
 57568.68%
*******
*******
*******
*******
Total Assets
*******
 99961.56%
*******
*******
*******
*******
Profit or Loss
*******
 6049.73%
*******
*******
*******
*******
Net Worth
*******
 100325.77%
*******
*******
*******
*******
EBITDA
*******
 -446152.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Xion Pharmaceuticals?

Unlock access to Xion Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • The Cosmos Co-Operative Bank Limited : 0.55 Cr
  • Others : 0.25 Cr
Latest Charge Details
Date Lender Amount Status
07 Feb 2017 Others ₹2.50 M Open
26 Mar 2014 The Cosmos Co-Operative Bank Limited ₹5.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Xion Pharmaceuticals?

Unlock and access historical data on people associated with Xion Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Xion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xion Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Xion Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Xion Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Xion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 2.50 M with Charge ID 100080448 was registered on 07 Feb 2017. was recorded as a recent event.

  • Charges

    The activity A charge with The Cosmos Co-Operative Bank Limited amounted to Rs. 5.50 M with Charge ID 10495952 was registered on 26 Mar 2014. was completed.

  • Director Appointment

    Mahendra Champalal Jain was appointed as a Director was appointed as a Director on 04 Jun 2007 & has been associated with this company since 18 years 9 months . was recorded as a recent event.

  • Director Appointment

    Rajeshkumar Champalal Jain was appointed as a Director was appointed as a Director on 04 Jun 2007 & has been associated with this company since 18 years 9 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Xion Pharmaceuticals Private Limited?

The CIN of Xion Pharmaceuticals Private Limited is U24231PN2007PTC130248.

Where is Xion Pharmaceuticals Private Limited headquartered?

Xion Pharmaceuticals Private Limited is headquartered at Office No. 102 & 103, Park Plaza, First Floor, Opp Kamala Nehru Park, Erandwane,, Pune, Maharashtra, 411004.

When was Xion Pharmaceuticals Private Limited incorporated?

Xion Pharmaceuticals Private Limited was incorporated on 04 June 2007.

Who are the current directors of Xion Pharmaceuticals Private Limited?

The current directors of Xion Pharmaceuticals Private Limited are

What is the primary industry of Xion Pharmaceuticals Private Limited?

The primary industry of Xion Pharmaceuticals Private Limited is Trade.

Is Xion Pharmaceuticals Private Limited a listed company?

Xion Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Xion Pharmaceuticals Private Limited?

The authorized capital of Xion Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Xion Pharmaceuticals Private Limited?

The compliance status of Xion Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available